BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu J, Li T, Du X, Wu Q, Le YZ. G protein-coupled receptor 91 signaling in diabetic retinopathy and hypoxic retinal diseases. Vision Res. 2017;139:59-64. [PMID: 28539261 DOI: 10.1016/j.visres.2017.05.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 González-Casanova J, Schmachtenberg O, Martínez AD, Sanchez HA, Harcha PA, Rojas-Gomez D. An Update on Connexin Gap Junction and Hemichannels in Diabetic Retinopathy. Int J Mol Sci 2021;22:3194. [PMID: 33801118 DOI: 10.3390/ijms22063194] [Reference Citation Analysis]
2 Lim R, Lappas M. Inhibition of GPR91 Reduces Inflammatory Mediators Involved in Active Labor in Myometrium. Mediators Inflamm 2020;2020:6454282. [PMID: 32377163 DOI: 10.1155/2020/6454282] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Forrester JV, Kuffova L, Delibegovic M. The Role of Inflammation in Diabetic Retinopathy. Front Immunol. 2020;11:583687. [PMID: 33240272 DOI: 10.3389/fimmu.2020.583687] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
4 Webb M, Sideris DP. Intimate Relations-Mitochondria and Ageing. Int J Mol Sci 2020;21:E7580. [PMID: 33066461 DOI: 10.3390/ijms21207580] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Trauelsen M, Rexen Ulven E, Hjorth SA, Brvar M, Monaco C, Frimurer TM, Schwartz TW. Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91. Mol Metab 2017;6:1585-96. [PMID: 29157600 DOI: 10.1016/j.molmet.2017.09.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
6 Potilinski MC, Lorenc V, Perisset S, Gallo JE. Mechanisms behind Retinal Ganglion Cell Loss in Diabetes and Therapeutic Approach. Int J Mol Sci 2020;21:E2351. [PMID: 32231131 DOI: 10.3390/ijms21072351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Terra X, Ceperuelo-Mallafré V, Merma C, Benaiges E, Bosch R, Castillo P, Flores JC, León X, Valduvieco I, Basté N, Cámara M, Lejeune M, Gumà J, Vendrell J, Vilaseca I, Fernández-Veledo S, Avilés-Jurado FX. Succinate Pathway in Head and Neck Squamous Cell Carcinoma: Potential as a Diagnostic and Prognostic Marker. Cancers (Basel) 2021;13:1653. [PMID: 33916314 DOI: 10.3390/cancers13071653] [Reference Citation Analysis]
8 Zhang S, Liang Y, Li L, Chen Y, Wu P, Wei D. Succinate: A Novel Mediator to Promote Atherosclerotic Lesion Progression. DNA Cell Biol 2022. [PMID: 35138943 DOI: 10.1089/dna.2021.0345] [Reference Citation Analysis]
9 Hartnett ME, Baehr W, Le YZ. Diabetic retinopathy, an overview. Vision Res 2017;139:1-6. [PMID: 28757399 DOI: 10.1016/j.visres.2017.07.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
10 Herat LY, Ward NC, Magno AL, Rakoczy EP, Kiuchi MG, Schlaich MP, Matthews VB. Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice. World J Gastroenterol 2020; 26(23): 3225-3235 [PMID: 32684737 DOI: 10.3748/wjg.v26.i23.3225] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Jin J, Wang H, Hua X, Chen D, Huang C, Chen Z. An outline for the pharmacological effect of icariin in the nervous system. Eur J Pharmacol 2019;842:20-32. [PMID: 30342950 DOI: 10.1016/j.ejphar.2018.10.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]